Colleen Kusy is a Baird Senior Research Analyst covering Biotechnology. Colleen joined Baird in 2014. Prior to her current role, she spent over six years as a sell-side associate covering biotechnology stocks across a range of therapeutic areas and market caps at Baird. She started her career as a business analyst within the Fixed Income Capital Markets group at Baird. Colleen received a BS in Finance from Villanova University.